N. Charland

发表

Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages

I. Rouiller, A. Makarkov, M. Golizeh, 2019, npj Vaccines.

Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.

Cheng-Ying Wu, S. Pillet, N. Charland, 2017, Vaccine.

Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada

M. Laskowski, D. Champredon, S. Moghadas, 2018, Scientific Reports.

Strategies for Early Vaccination During Novel Influenza Outbreaks

S. Moghadas, N. Charland, S. M. Moghadas, 2015, Scientific Reports.

Projected impact of a plant-derived vaccine on the burden of seasonal influenza in Canada

C. Bauch, N. Charland, G. Tremblay, 2021, Human vaccines & immunotherapeutics.

Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.

C. Krawczyk, N. Charland, N. Landry, 2018, Vaccine.

Streptococcus suis Serotype 2 Interactions with Human Brain Microvascular Endothelial Cells

V. Nizet, K. Kim, M. Gottschalk, 2000, Infection and Immunity.

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine

L. Moulton, F. Polack, G. Pérez Marc, 2022, The New England journal of medicine.

Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2.

M. Jacques, M. Gottschalk, N. Charland, 1997, Microbiology.

Durability and Cross-Reactivity of Immune Responses Induced by an AS03 Adjuvanted Plant-Based Recombinant Virus-Like Particle Vaccine for COVID-19

D. Vinh, Marc‐André D'Aoust, S. Pillet, 2021, medRxiv.

Exploiting IL-1 Signaling in Both Adult and Aged Mice Vaccine Generates an Efficacious Cellular Response by A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle

S. Pillet, N. Charland, B. Ward, 2022 .

Streptococcus pneumoniae types 19A and 19F and Streptococcus suis capsular type 8 share common capsular epitopes

M. Jacques, M. Gottschalk, N. Charland, 1995, Journal of clinical microbiology.

Contact-dependent acquisition of transferrin=botrnd iron by two strains of Haemophilrrs parasuisl H. Charland, C.G. D98iIva, W,A. Dumsnt, and D.F. Hiwen

N. Charland, 1995 .

Prevention of Pneumococcal Disease in Mice Immunized with Conserved Surface-Accessible Proteins

N. Charland, Catherine Ouellet, J. Hamel, 2004, Infection and Immunity.

Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities

D. Vinh, Marc‐André D'Aoust, A. Makarkov, 2022, npj Vaccines.

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

L. Vézina, Marc‐André D'Aoust, N. Charland, 2010, Plant biotechnology journal.

Evaluation of a saline boiled extract, capsular polysaccharides and long-chain lipopolysaccharides of Actinobacillus pleuropneumoniae serotype 1 as antigens for the serodiagnosis of swine pleuropneumonia.

M. Gottschalk, N. Charland, J. Dubreuil, 1994, Veterinary microbiology.

Streptococcus suis serotype 2 mutants deficient in capsular expression.

J. Harel, M. Gottschalk, N. Charland, 1998, Microbiology.

The adjuvant GLA-AF enhances human intradermal vaccine responses

S. Reed, D. Carter, A. Magill, 2018, Science Advances.

Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates

B. Pulendran, S. Boyd, G. Andreani, 2021, bioRxiv.

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

B. Pulendran, S. Boyd, G. Andreani, 2022, Cellular & molecular immunology.

Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae.

T. Mitchell, N. Charland, J. Poolman, 2011, Microbiology.

The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?

S. Pillet, N. Charland, N. Landry, 2018, Human vaccines & immunotherapeutics.

Protection from Group B Streptococcal Infection in Neonatal Mice by Maternal Immunization with Recombinant Sip Protein

N. Charland, J. Hamel, B. Brodeur, 2002, Infection and Immunity.

Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03

L. Moulton, F. Polack, Marc‐André D'Aoust, 2022, medRxiv.

Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada

M. Laskowski, D. Champredon, S. Moghadas, 2018, Scientific Reports.

Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2.

M. Jacques, M. Gottschalk, N. Charland, 1996, FEMS immunology and medical microbiology.

Agglutination of Streptococcus suis by sialic acid-binding lectins

M. Gottschalk, N. Charland, J. Kellens, 1995, Journal of Clinical Microbiology.

Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19

G. Alter, S. Pillet, N. Charland, 2023, npj Vaccines.

Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19

D. Vinh, Marc‐André D'Aoust, S. Pillet, 2022, Nature Communications.

Universal Proteins As an Alternative Bacterial Vaccine Strategy

N. Charland, J. Hamel, B. Brodeur, 2003 .

Martine Immunization with Recombinant Sip Protein Infection in Neonatal Mice by Maternal Protection from Group B Streptococcal

N. Charland, J. Hamel, B. Brodeur, 2002 .

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

B. Pulendran, S. Boyd, G. Andreani, 2022, Cellular & Molecular Immunology.

Contact-dependent acquisition of transferrin-bound iron by two strains of Haemophilus parasuis.

R. Dumont, N. Charland, D. F. Niven, 1995, Canadian Journal of Microbiology (print).

A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle Vaccine Generates an Efficacious Cellular Response by Exploiting IL-1 Signaling in Both Adult and Aged Mice

S. Pillet, N. Charland, B. Ward, 2022, ImmunoHorizons.

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

L. Vézina, Marc‐André D'Aoust, N. Charland, 2010, Plant biotechnology journal.